Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Novo Nordisk and Valo Health Expand Partnership to Develop Treatments for Obesity and Diabetes
CompanyDeals

Novo Nordisk and Valo Health Expand Partnership to Develop Treatments for Obesity and Diabetes

January 11, 2025
Immunochina Pharmaceuticals Raises Series E Funding for CAR-T Therapy IM19
CompanyDeals

Immunochina Pharmaceuticals Raises Series E Funding for CAR-T Therapy IM19

January 11, 2025
Sinogen's SalMet-Vec Receives FDA Orphan Drug Designation for Pancreatic Cancer
CompanyDrug

Sinogen’s SalMet-Vec Receives FDA Orphan Drug Designation for Pancreatic Cancer

January 10, 2025
SynCardia's Next-Generation Artificial Heart Granted Patent in China
Legal / IP

SynCardia’s Next-Generation Artificial Heart Granted Patent in China

January 10, 2025
CompanyDeals

Zai Lab and MediLink Therapeutics Partner to Develop LRRC15 ADC Drug ZL-6201 for Solid Tumors

February 28, 2025
Danaher Corporation Partners with Innovaccer to Enhance Healthcare AI Solutions
CompanyDeals

Danaher Corporation Partners with Innovaccer to Enhance Healthcare AI Solutions

January 10, 2025
Sanofi's Sarclisa Meets Co-Primary Endpoints in Phase III IRAKLIA Study for Multiple Myeloma
CompanyDrug

Sanofi’s Sarclisa Meets Co-Primary Endpoints in Phase III IRAKLIA Study for Multiple Myeloma

January 10, 2025
FDA Grants Priority Review to Johnson & Johnson's Nipocalimab for Myasthenia Gravis
CompanyDrug

FDA Grants Priority Review to Johnson & Johnson’s Nipocalimab for Myasthenia Gravis

January 10, 2025
Boehringer Ingelheim Licenses ADC Technology from Synaffix to Boost Portfolio
CompanyDeals

Boehringer Ingelheim Licenses ADC Technology from Synaffix to Boost Portfolio

January 10, 2025
Alchemab Therapeutics Partners with Eli Lilly to Discover ALS Treatments
CompanyDeals

Alchemab Therapeutics Partners with Eli Lilly to Discover ALS Treatments

January 10, 2025
Roche Gains FDA 510(k) Clearance for Roche Digital Pathology Dx with VENTANA DP 600
CompanyMedical Device

Roche Gains FDA 510(k) Clearance for Roche Digital Pathology Dx with VENTANA DP 600

January 10, 2025
TCMTech Files for IPO on Hong Kong Stock Exchange, Showcasing TCM AI Leadership
CompanyDeals

TCMTech Files for IPO on Hong Kong Stock Exchange, Showcasing TCM AI Leadership

January 10, 2025
1 2 … 277 278 279 280 281 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up